It has been about a month since the last earnings report for Johnson & Johnson (JNJ). Shares have lost about 6.7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Tomaso Zambelli, CEO of SoniVie, said "We look forward to benefiting from Mr. Cohen's broad experience in growing Medtech companies and moreover his expertise in renal denervation as we execute our ...

Optimized to drive a wide range of magnetron models with peak RF power of up to 2 MW, the M060 is engineered for adaptability across diverse environments. The modulator leverages cutting-edge ...

ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Employees have the option to look for other jobs in the company, Haemonetics said in the Oct. 22 letter provided to MedTech ...

Johnson & Johnson MedTech announced today that it entered into an exclusive commercial distribution agreement with Responsive Arthroscopy. The company agreed to a deal in the U.S. with Responsive ...

About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of ...

The IDE will allow the medtech giant to conduct clinical trials at US sites with the robotic surgical system called Ottava.

In a post on his Instagram account, Schwarzenegger said he is eager to join Zimmer Biomet in the unique role and utilize his ...